Polymerase chain reaction--restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter

Mina Booka1, Masumi Okuda, Kouichirou Shin

  • 1Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.

Helicobacter
|May 21, 2005
PubMed

Insights

A new polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method using stool samples can rapidly detect clarithromycin-resistant Helicobacter pylori infection in children. This noninvasive technique aids in selecting effective H. pylori eradication treatments.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Molecular Diagnostics

Background:

  • Helicobacter pylori infection is a significant global health concern, particularly in children.
  • Antibiotic resistance, especially to clarithromycin, complicates eradication therapy.
  • Noninvasive diagnostic methods are crucial for pediatric patient management.

Purpose of the Study:

  • To develop and validate a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay for detecting clarithromycin-resistant H. pylori in pediatric stool samples.
  • To assess the prevalence of clarithromycin resistance in H. pylori infections among children.

Main Methods:

  • A novel PCR-RFLP method was established targeting the 23S rRNA gene of H. pylori in stool DNA.
  • Restriction enzymes MboII, BceAI, and BsaI were used to identify specific resistance mutations (A2142G, A2142C, A2143G).
  • The assay was validated against the H. pylori stool antigen test (HpSA) in a cohort of 23 children.

Main Results:

  • The PCR-RFLP assay demonstrated 89% sensitivity, 100% specificity, and 91% accuracy compared to HpSA.
  • Out of 16 H. pylori-positive samples, 31% showed resistance to clarithromycin based on enzyme digestion patterns.
  • The method successfully identified clarithromycin resistance mutations in pediatric stool samples.

Conclusions:

  • PCR-RFLP using stool samples is a rapid, reliable, and noninvasive method for detecting clarithromycin-resistant H. pylori in children.
  • This diagnostic approach can guide the selection of appropriate H. pylori eradication regimens.
  • The findings highlight the utility of molecular methods in pediatric infectious disease diagnostics.
Abstract